Internal Medicine, Hematology & Oncology · Danville, VA
NPI
1881990505
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
125 Executive Dr, Suite J
Danville, VA, 24541
Phone (434) 793-0044
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,452 services
Medicare patients, 2024
450
Average age 75
Drug cost, 2024
$7.6M
2,816 prescriptions
Company payments, 2025
$1,641
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Akintunde R Akinleye was code 99214 (office e&m - established), 1,016 times for 337 patients. In total Akintunde R Akinleye billed 1,452 services in 12 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,016 | 337 | $66.64 | $68K |
| 99213 Office E&M - Established | Facility | 253 | 121 | $44.05 | $11K |
| 99204 Office E&M - New | Facility | 43 | 43 | $91.59 | $3,939 |
| 99205 Office E&M - New | Facility | 31 | 31 | $131.64 | $4,081 |
| 99215 Office E&M - Established | Facility | 30 | 25 | $102.29 | $3,069 |
| 99223 Hospital E&M - Initial | Facility | 27 | 24 | $131.92 | $3,562 |
| 38222 Other Organ Systems | Facility | 15 | 15 | $48.56 | $728 |
By year: 2022 $90K for 1,364 services; 2023 $103K for 1,546 services; 2024 $95K for 1,452 services.
Medicare prescription drug claims, 2024
In 2024, the drug Akintunde R Akinleye prescribed most often to Medicare patients was Letrozole, with 360 prescriptions and refills. In total Akintunde R Akinleye wrote 2,816 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 360 | 852 | 100 | $9,633 |
| Acyclovir Generic | 159 | 335 | 44 | $3,662 |
| Alendronate Sodium Generic | 141 | 338 | 41 | $971 |
| Eliquis Apixaban | 114 | 172 | 23 | $98K |
| Hydroxyurea Generic | 109 | 264 | 27 | $2,249 |
| Anastrozole Generic | 81 | 217 | 22 | $1,558 |
| Potassium Chloride Generic | 77 | 101 | 34 | $848 |
| Lenalidomide Generic | 76 | 76 | 11 | $1.1M |
| Ondansetron Odt Ondansetron | 72 | 72 | 43 | $5,827 |
| Abiraterone Acetate Generic | 63 | 69 | Under 11 | $432K |
| Gabapentin Generic | 58 | 78 | 19 | $1,172 |
| Prochlorperazine Maleate Generic | 54 | 55 | 40 | $1,664 |
| Revlimid Lenalidomide | 54 | 54 | 15 | $1.1M |
| Ibrance Palbociclib | 53 | 53 | Under 11 | $826K |
| Oxycodone Hcl Generic | 50 | 50 | 14 | $1,040 |
Brand drugs: 568 claims; generic drugs: 2,248 claims; opioid claims: 176.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Akintunde R Akinleye $1,641 ($1,641 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,049.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 12 | $1,049 |
| Incyte Corporation INCY | 2 | $118 |
| Janssen Biotech, Inc. JNJ | 5 | $89.72 |
| Pfizer Inc. PFE | 2 | $57.06 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $51.26 |
| GlaxoSmithKline, LLC. GSK | 2 | $40.94 |
| Caris MPI, Inc. | 1 | $27.49 |
| Servier Pharmaceuticals LLC | 1 | $23.73 |
| Stemline Therapeutics Inc. | 1 | $23.72 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $23.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.